Sea Crest Wealth Management, LLC Acadia Pharmaceuticals Inc Transaction History

Sea Crest Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$14.32 - $22.92 $230,552 - $369,012	-16,100 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$13.03 - $21.81 $209,783 - $351,141	16,100 New	16,100 $334,000
Q2 2018 Aug 03, 2018	SELL	$15.07 - $22.34 $7,535 - $11,170	-500 Closed	0 $0
Q1 2018 Apr 20, 2018	SELL	$22.47 - $32.33 $15,729 - $22,631	-700 Reduced 58.33%	500 $11,000
Q4 2017 Feb 02, 2018	BUY	$26.84 - $39.14 $32,208 - $46,968	1,200	1,200 $36,000

299

158M

1.88M

688K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.